Kenneth Galbraith
2022
In 2022, Kenneth Galbraith earned a total compensation of $7.1M as Chair CEO current President at Zymeworks.
Compensation breakdown
| Non-Equity Incentive Plan | $537,728 |
|---|---|
| Option Awards | $5,044,999 |
| Salary | $582,481 |
| Stock Awards | $879,000 |
| Other | $81,249 |
| Total | $7,125,457 |
Galbraith received $5M in option awards, accounting for 71% of the total pay in 2022.
Galbraith also received $537.7K in non-equity incentive plan, $582.5K in salary, $879K in stock awards and $81.2K in other compensation.
Rankings
In 2022, Kenneth Galbraith's compensation ranked 401st out of 5,625 executives tracked by ExecPay. In other words, Galbraith earned more than 92.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 401 out of 5,625 | 93rd |
Division Manufacturing | 165 out of 3,053 | 95th |
Major group Chemicals And Allied Products | 42 out of 1,380 | 97th |
Industry group Drugs | 31 out of 1,281 | 98th |
Industry Pharmaceutical Preparations | 23 out of 927 | 98th |
Source: SEC filing on October 26, 2023.
Galbraith's colleagues
We found three more compensation records of executives who worked with Kenneth Galbraith at Zymeworks in 2022.